about
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayc...
Read More
120.00
-3.98
(-3.21%)
3.4M
XNAS Volume
XNAS 18 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Insmed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..